An Exploratory Clinical Study of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA Nephropathy
Clinical trial NCT06926985 · WITHDRAWN
Trial details
- NCT number
- NCT06926985
- Sponsor
- Jieyang People's Hospital
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2026-04-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.